| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,116 |
7,475 |
$222K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,647 |
1,544 |
$67K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
136 |
132 |
$10K |
| 99385 |
|
120 |
117 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
813 |
598 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,895 |
2,688 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
62 |
61 |
$4K |
| 3074F |
|
4,320 |
3,548 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
56 |
52 |
$3K |
| 3075F |
|
1,661 |
1,446 |
$2K |
| 93000 |
|
381 |
375 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
25 |
$902.91 |
| 82962 |
|
326 |
290 |
$356.44 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
97 |
89 |
$154.07 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
116 |
103 |
$148.76 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
29 |
14 |
$75.00 |
| 3049F |
|
184 |
166 |
$60.12 |
| 3078F |
|
3,532 |
2,968 |
$37.83 |
| 81002 |
|
30 |
27 |
$29.69 |
| 3008F |
|
3,810 |
3,266 |
$25.22 |
| 3079F |
|
2,094 |
1,774 |
$25.22 |
| 3725F |
|
2,592 |
2,293 |
$25.22 |
| 1159F |
|
3,561 |
2,911 |
$12.61 |
| 1160F |
|
4,219 |
3,397 |
$12.61 |
| 1036F |
|
2,599 |
2,287 |
$0.00 |
| 3044F |
|
822 |
736 |
$0.00 |
| 1125F |
|
629 |
511 |
$0.00 |
| 1126F |
|
2,125 |
1,750 |
$0.00 |
| 96127 |
|
52 |
52 |
$0.00 |
| 3014F |
|
94 |
71 |
$0.00 |
| 3048F |
|
327 |
304 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15 |
12 |
$0.00 |
| 4010F |
|
337 |
253 |
$0.00 |
| 1111F |
|
128 |
121 |
$0.00 |
| 1034F |
|
64 |
56 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19 |
16 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
65 |
59 |
$0.00 |
| 3017F |
|
37 |
28 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
61 |
55 |
$0.00 |
| 4013F |
|
680 |
513 |
$0.00 |
| 4004F |
|
158 |
146 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
125 |
114 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
101 |
87 |
$0.00 |
| 3050F |
|
56 |
51 |
$0.00 |